{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:06:08Z","timestamp":1791173168279,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T00:00:00Z","timestamp":1342569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-295","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T10:13:47Z","timestamp":1342606427000},"source":"Crossref","is-referenced-by-count":35,"title":["Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Falk","family":"Roeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Timke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Habl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank W","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus W","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krempien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,18]]},"reference":[{"key":"3212_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics 2009. CA Cancer J Clin. 2009, 59: 225-249. 10.3322\/caac.20006.","journal-title":"CA Cancer J Clin"},{"key":"3212_CR2","first-page":"676","volume":"9","author":"BW Chang","year":"2008","unstructured":"Chang BW, Saif MW: Stereotactic body radiation therapy (SBRT) in pancreatic cancer : Is it ready for prime time?. J Pancreas. 2008, 9: 676-682.","journal-title":"J Pancreas"},{"key":"3212_CR3","first-page":"545","volume":"8","author":"MW Saif","year":"2007","unstructured":"Saif MW: Controversies in the adjuvant treatment of pancreatic cancer. J Pancreas. 2007, 8: 545-552.","journal-title":"J Pancreas"},{"key":"3212_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer \u2013 a randomized controlled trial. JAMA. 2007, 297: 267-277. 10.1001\/jama.297.3.267.","journal-title":"JAMA"},{"key":"3212_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","volume":"10","author":"S Hishinuma","year":"2006","unstructured":"Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirybayashi K, Igarashi S: Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006, 10: 511-518. 10.1016\/j.gassur.2005.09.016.","journal-title":"J Gastrointest Surg"},{"key":"3212_CR6","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.ijrobp.2006.11.039","volume":"67","author":"F Roeder","year":"2007","unstructured":"Roeder F, Treiber M, Oertel S, Dinke J, Timke C, Funk A, Garcia-Huttenlocher H, Bischof M, Weitz J, Harms W, Hensley FW, Buchler MW, Debus J, Krempien R: Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2007, 67: 1381-1388. 10.1016\/j.ijrobp.2006.11.039.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3212_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.ijrobp.2006.01.028","volume":"65","author":"R Krempien","year":"2006","unstructured":"Krempien R, Roeder F, Oertel S, Weitz J, Hensley FW, Timke C, Funk A, Lindel K, Harms W, Buchler MW, Debus J, Treiber M: Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2006, 65: 773-779. 10.1016\/j.ijrobp.2006.01.028.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl","key":"3212_CR8","first-page":"15","volume":"26","author":"PJ Loehrer","year":"2008","unstructured":"Loehrer PJ, Powell ME, Cardenes HR, Wagner L, Brell JM, Ramanathan RK, Crane CH, Alberts SR, Benson AS: A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201. J Clin Oncol. 2008, 26 (Suppl): 15-","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"3212_CR9","first-page":"18","volume":"24","author":"E Poplin","year":"2006","unstructured":"Poplin E, Levy D, Berlin J, Rotheberg ML, O\u2019Dwyer PJ, Cella D, Mitchell E, Alberts S, Benson A: Phase III trial of gemcitabine (30-min infusion) versus gemcitabine (fixed-dose-rate infusion[FDR]) versus gemcitabine + oxaliplatin (GEMOX) in patients with advanced pancreatic cancer (E6201). J Clin Oncol. 2006, 24 (suppl): 18-","journal-title":"J Clin Oncol"},{"key":"3212_CR10","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1200\/JCO.2010.28.1386","volume":"28","author":"HL Kindler","year":"2010","unstructured":"Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O\u2019Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM: Gemcitabine Plus Bevacizumab compared with Gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the cancer and leukaemia group B (CALGB 80303). J Clin Oncol. 2010, 28: 3617-3622. 10.1200\/JCO.2010.28.1386.","journal-title":"J Clin Oncol"},{"key":"3212_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1136\/gut.2010.216135","volume":"59","author":"L Dahan","year":"2010","unstructured":"Dahan L, Bonnetain F, Ychou M, Miltry E, Gasmi M, Raoul JL, Cattan S, Phelip JM, Hammel P, Chauffert B, Michel P, Legoux JL, Rougier P, Bedenne L, Seitz JF: Combination of 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301). Gut. 2010, 59: 1527-1534. 10.1136\/gut.2010.216135.","journal-title":"Gut"},{"key":"3212_CR12","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1200\/JCO.2009.25.7550","volume":"28","author":"PA Philip","year":"2010","unstructured":"Philip PA, Benedetti J, Corless CL, Wong R, O\u2019Reilly EM, Flynn PJ, Rowland KM, Atkins JN, Mirtsching BC, Rivkin SE, Khorana AA, Goldman B, Fenoglio-Preiser CM, Abbruzzese JL, Blanke CD: Phase III Study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma : Southwest Oncology Group-directed Intergroup Trial S0205. J Clin Oncol. 2010, 28: 3605-3610. 10.1200\/JCO.2009.25.7550.","journal-title":"J Clin Oncol"},{"key":"3212_CR13","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1200\/JCO.2009.21.8529","volume":"27","author":"CH Crane","year":"2009","unstructured":"Crane CH, Winter K, Regine W, Safran H, Rich TA, Curran W, Wolff RA, Willett CG: Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. J Clin Oncol. 2009, 27: 4096-4102. 10.1200\/JCO.2009.21.8529.","journal-title":"J Clin Oncol"},{"key":"3212_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/01.coc.0000046300.88847.BF","volume":"27","author":"T Rich","year":"2004","unstructured":"Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W, Safran H, Wanebo HJ: Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol. 2004, 27: 51-56. 10.1097\/01.coc.0000046300.88847.BF.","journal-title":"Am J Clin Oncol"},{"key":"3212_CR15","first-page":"121","volume-title":"A randomized phase II trial of weekly gemcitabine (G), paclitaxel (P) and external irradiation followed by the farnesyl transferase inhibitor R115777(NSC#702818) for locally advanced pancreatic cancer (RTOG 0020). In Proceedings of the ASCO Gastrointestina","author":"TA Rich","year":"2006","unstructured":"Rich TA, Myerson R, Harris J, Safran H, Hoffman JP, Erickson B, Willett C, Anne PR, Myerson RJ, Cline-Burkhardt M: A randomized phase II trial of weekly gemcitabine (G), paclitaxel (P) and external irradiation followed by the farnesyl transferase inhibitor R115777(NSC#702818) for locally advanced pancreatic cancer (RTOG 0020). In Proceedings of the ASCO Gastrointestinal Cancer Symposium: 26-28 January 2006. 2006, San Francisco, 121-"},{"key":"3212_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ijrobp.2007.01.005","volume":"68","author":"AH Ko","year":"2007","unstructured":"Ko AH, Quivey JM, Venook AP, Bergsland EK, Dito E, Schillinger B, Tempero MA: A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2007, 68: 809-816. 10.1016\/j.ijrobp.2007.01.005.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3212_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/annonc\/mdm441","volume":"19","author":"A Duffy","year":"2008","unstructured":"Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O\u2019Reilly EM: A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, nonoperable pancreatic adenocarcinoma. Ann Oncol. 2008, 19: 86-91.","journal-title":"Ann Oncol"},{"key":"3212_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/cncr.24069","volume":"115","author":"CH Crane","year":"2009","unstructured":"Crane CH, Willet CG: Stereotactic radiotherapy for pancreatic cancer?. Cancer. 2009, 115: 468-72. 10.1002\/cncr.24069.","journal-title":"Cancer"},{"key":"3212_CR19","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1200\/JCO.2010.30.3446","volume":"28","author":"JL van Laethem","year":"2010","unstructured":"van Laethem JL, Hammel P, Mornex F, Azria D, van Tienhoven G, Vergauwe P, Peeters M, Polus M, Praet M, Mauer M, Collette L, Budach V, Lutz M, can Cutsem E, Haustermans K: Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer : A randomized EORTC-40013-22012\/FFCD-9203\/GERCOR phase II study. J Clin Oncol. 2010, 28: 4450-4456. 10.1200\/JCO.2010.30.3446.","journal-title":"J Clin Oncol"},{"key":"3212_CR20","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ijrobp.2007.07.2346","volume":"70","author":"V Valentini","year":"2008","unstructured":"Valentini V, Morganti A, Macchia G, Mantini G, Mattiucci GC, Brizi MG, Alfieri S, Bossola M, Pacelli F, Sofo L, Doglietto G, Cellini N: Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. Int J Radiat Oncol Biol Phys. 2008, 70: 1094-1099. 10.1016\/j.ijrobp.2007.07.2346.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3212_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ijrobp.2003.11.004","volume":"58","author":"AC Koong","year":"2004","unstructured":"Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho G, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA: Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004, 58: 1017-21. 10.1016\/j.ijrobp.2003.11.004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3212_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijrobp.2005.07.002","volume":"63","author":"AC Koong","year":"2005","unstructured":"Koong AC, Christofferson E, Le QT, Goodman KA, Ho A, Kuo T, Ford JM, Fisher GA, Greco R, Norton J, Yang GP: Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2005, 63: 320-3. 10.1016\/j.ijrobp.2005.07.002.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3212_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijrobp.2009.08.046","volume":"78","author":"A Mahadevan","year":"2010","unstructured":"Mahadevan A, Jain S, Goldstein M, Miksad R, Plsekow D, Sawhney M, Brennan D, Callery M, Vollmer C: Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2010, 78: 735-742. 10.1016\/j.ijrobp.2009.08.046.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3212_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","volume":"18","author":"JP Kirkpatrick","year":"2008","unstructured":"Kirkpatrick JP, Meyer JJ, Marks LB: The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Sem Radiat Oncol. 2008, 18: 240-3. 10.1016\/j.semradonc.2008.04.005.","journal-title":"Sem Radiat Oncol"},{"key":"3212_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.critrevonc.2005.11.004","volume":"59","author":"FA Calvo","year":"2006","unstructured":"Calvo FA, Meirino RM, Orecchia R: Intraoperative radiation therapy first part: rationale and techniques. Crit Rev Oncol Hematol. 2006, 59: 106-115. 10.1016\/j.critrevonc.2005.11.004.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3212_CR26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/0360-3016(93)90537-6","volume":"27","author":"GR Garton","year":"1993","unstructured":"Garton GR, Gunderson LL, Nagorney DM, Donohue JH, Martin JK, McIlrath DC, Cha SS: High dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 1993, 27: 1153-1157. 10.1016\/0360-3016(93)90537-6.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3212_CR27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/1097-0142(19880315)61:6<1110::AID-CNCR2820610610>3.0.CO;2-6","volume":"61","author":"GE Roldan","year":"1988","unstructured":"Roldan GE, Gunderson LL, Nagorney DM, Martin JK, Ilstrup DM, Holbrook MA, Kvols LK, McIllrath DC: External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer. 1988, 61: 1110-1116. 10.1002\/1097-0142(19880315)61:6<1110::AID-CNCR2820610610>3.0.CO;2-6.","journal-title":"Cancer"},{"key":"3212_CR28","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1200\/JCO.1995.13.11.2764","volume":"13","author":"M Mohiuddin","year":"1995","unstructured":"Mohiuddin M, Regine WF, Stevens J, Rosato F, Barbot D, Biermann W, Cantor R: Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol. 1995, 13: 2764-2768.","journal-title":"J Clin Oncol"},{"key":"3212_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/01.sla.0000152016.40331.bb","volume":"241","author":"CG Willett","year":"2005","unstructured":"Willett CG, Del Castillo CF, Shih H, Goldberg S, Biggs P, Clark JW, Lauwers G, Ryan DP, Zhu AX, Warshaw AL: Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer. Ann Surg. 2005, 241: 295-299. 10.1097\/01.sla.0000152016.40331.bb.","journal-title":"Ann Surg"},{"key":"3212_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.radonc.2008.07.020","volume":"91","author":"V Valentini","year":"2009","unstructured":"Valentini V, Calvo F, Reni M, Krempien F, Sedlmayer F, Buchler MW, Di Carlo V, Doglietto GB, Fastner G, Garcia-Sabrido JL, Mattiucci G, Morganti AG, Passoni P, Roeder F, D\u2019Agostino GR: Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT Europe experience. Radiother Oncol. 2009, 91: 54-59. 10.1016\/j.radonc.2008.07.020.","journal-title":"Radiother Oncol"},{"key":"3212_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijrobp.2012.01.008","volume":"83","author":"A Baschnagel","year":"2011","unstructured":"Baschnagel A, Shah C, Margolis J, Nadeau L, Stein J, Jury R, Robertson JM: Survival after chemoradiation in resected pancreatic cancer: The impact of adjuvant gemcitabine. Int J Radiat Oncol Biol Phys. 2011, 83: 331-5.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3212_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/01.COC.0000071462.12769.35","volume":"27","author":"FA Calvo","year":"2004","unstructured":"Calvo FA, Matute R, Garcia-Sabrido JL, Gomez-Espi M, Martinez NE, Lozano MA, Herranz R: Neoadjuvant chemoradiation with tegafur in cancer of the pancreas. Am J Clin Oncol. 2004, 27: 343-349. 10.1097\/01.COC.0000071462.12769.35.","journal-title":"Am J Clin Oncol"},{"key":"3212_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00000421-200302000-00007","volume":"26","author":"J Aristu","year":"2003","unstructured":"Aristu J, Canon R, Pardo F, Martinez-Monge R, Martin-Algarra S, Manuel Ordnonez J, Villafranca E, Moreno M, Cambeiro M, Azinovic I: Surgical resection after preoperative chemoradiotherapy benefits selcted patients with unresectable pancreatic cancer. Am J Clin Oncol. 2003, 26: 30-36. 10.1097\/00000421-200302000-00007.","journal-title":"Am J Clin Oncol"},{"key":"3212_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0360-3016(01)01470-5","volume":"50","author":"M Reni","year":"2001","unstructured":"Reni M, Panucci MG, Ferreri AJ, Balzano G, Passoni P, Cattaneo GM, Cordio S, Scaglietti U, Zerbi A, Ceresoli GL, Fiorino C, Calandrino R, Staudacher C, Villa E, Di Carlo V: Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2001, 50: 651-658. 10.1016\/S0360-3016(01)01470-5.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-295\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T21:28:24Z","timestamp":1497994104000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3212"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-295","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,18]]},"article-number":"295"}}